Earum Pharmaceuticals Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Earum Pharmaceuticals Limited's successfully completed its Initial Public Offering and commenced trading on Jul 04, 2019 at the BSE exchange. The company raised 18,48,000 Shares through this public offering, comprising TBD in fresh capital.
The IPO was priced within the band of ₹36 to ₹36, with minimum application lots of 3000 shares. The offering attracted significant investor interest during its subscription period from Jun 21, 2019 to Jun 26, 2019.
Share allotment was finalized on Jul 01, 2019, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in the trading, marketing, and distribution of pharmaceutical formulation products, with a portfolio of around 125 formulations including multivitamins, gynaecology drugs, steroids, antibiotics, cerebral activators, and gastrointestinal medicines. The company is also involved in trading active pharmaceutical ingredients such as Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP, and operates through two main business models—marketing its own branded formulations and trading generic formulations of other brands, with about 24 products manufactured by third parties and sold under its own brand. Earum Pharmaceuticals operates a well-equipped warehouse in Ahmedabad, Gujarat, and has a presence in both domestic and international markets including South East Asia, Latin America, and Africa, while focusing on expanding its global footprint, improving market capabilities, and maintaining high-quality product standards.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Wide Product Range: Offers a broad selection of products.
- Experienced Promoter: Backed by 11+ years of industry experience.
- Quality Assurance: Maintains high quality standards.
NA
- Mr. Bhumishth Narendrabhai Patel
- Mrs. Payal Bhumishth Patel
Earum Pharmaceuticals Limited
Bigshare Services Private Limited